Vitamin c high dose therapy
Pro Research Analysisby 
Searched over 200M research papers
Safety of High-Dose Vitamin C Therapy
High-dose vitamin C therapy, especially when given intravenously, has been studied for its safety in both adults and children. In adults, large reviews of clinical trials found no consistent evidence that high-dose vitamin C is more harmful than placebo, though rare side effects like oxalate nephropathy, hypernatremia, hemolysis in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, and kidney stones have been reported, so monitoring is recommended for at-risk patients . In pediatric patients, studies found no evidence of harm or adverse events, but also no clear clinical benefit, suggesting that more research is needed in this group . In patients hospitalized with COVID-19, high-dose intravenous vitamin C was found to be safe, with no significant adverse reactions or negative effects on kidney function Corrao2024Gao2021.
Efficacy of High-Dose Vitamin C in Critical Illness and COVID-19
The effectiveness of high-dose vitamin C in critically ill patients, such as those with severe burns or COVID-19, has been explored. In severe burn patients, high-dose vitamin C (over 10 g within the first two days) was associated with reduced in-hospital mortality, but higher doses did not show additional benefit . For COVID-19, some studies suggest that high-dose vitamin C may reduce mortality and improve oxygen support status, but these findings are not yet definitive and require further confirmation Corrao2024Gao2021.
High-Dose Vitamin C in Cancer Therapy
Preclinical and Mechanistic Insights
Preclinical studies show that high-dose vitamin C can kill cancer cells and may work through several mechanisms, including pro-oxidant effects, modulation of DNA methylation, and influencing hypoxia pathways. These effects are most pronounced at plasma concentrations achievable only through intravenous administration Giansanti2021Mussa2022. There is also interest in combining vitamin C with other cancer therapies, such as PARP inhibitors and hypomethylating agents, based on its effects on DNA and cell metabolism Giansanti2021Mussa2022.
Clinical Evidence and Quality of Life
Despite promising laboratory results, clinical studies in advanced-stage cancer patients have not shown clear anti-cancer effects or improved survival with high-dose vitamin C. However, some evidence suggests it may help reduce cancer-related symptoms like fatigue and bone pain, potentially improving quality of life in palliative care settings . There is also evidence that high-dose vitamin C can reduce markers of inflammation, such as C-reactive protein (CRP) and pro-inflammatory cytokines, in cancer patients Park2020Mikirova2012. In breast cancer patients undergoing radiotherapy, high-dose vitamin C was associated with a significant reduction in the neutrophil-lymphocyte ratio, a marker linked to better outcomes .
Conclusion
High-dose vitamin C therapy is generally safe for most patients, with rare but important risks that require monitoring in specific populations. Its effectiveness varies by condition: it may reduce mortality in severe burns and improve some outcomes in COVID-19, but its role in cancer therapy remains limited to symptom management and reducing inflammation rather than direct anti-cancer effects. More robust, placebo-controlled trials are needed to clarify its benefits and optimal use in different patient groups.
Sources and full results
Most relevant research papers on this topic